Healthcare operator Nutex delays Q2 filing, posts 220% revenue gain

Nutex Health (NASDAQ: NUTX), a physician-led healthcare system with 24 micro hospitals across 11 states, announced three significant updates: preliminary Q2 2025 results, a Form 10-Q filing delay, and a $25 million stock repurchase program.

The company reported strong Q2 2025 performance with revenue of $244.0 million, up 220.7% year-over-year, and gross profit of $124.9 million (51.2% margin). Total hospital visits increased by 10.6% to 45,573. For H1 2025, revenue reached $455.8 million, up 217.5%, with gross profit of $243.3 million.

The Form 10-Q filing delay is due to non-cash accounting adjustments related to stock-based compensation for under-construction hospitals. The company expects to file within the five-day grace period and confirms these adjustments won't affect revenue, gross profit, or operations.

https://www.stocktitan.net/news/NUTX/nutex-health-provides-preliminary-second-quarter-financial-results-q8fxfugzr8dc.html